Status
Acquired by Bayer HealthCare on September 16, 2008
Funding Received
$33.2 Million in 3 Rounds from 7 Investors
Founded:
2000
Headquarters:
Cologne
Description:
DIREVO Industrial Biotechnology is focused on the biomass conversion industry and provides customized solutions for various industries.
Categories:
Biotechnology
Website:
http://www.direvo.com

Detailed Description

Update

DIREVO provides customized solutions for various industries via the development and optimization of biocatalysts with its proprietary ultra-high-throughput screening platform. Serving the Feed & Food industries and chemical / biorefinery businesses, DIREVO products are developed either independently or in conjunction with global leaders such as Genencor (a division of Danisco A/S), AB Enzymes, Roal Ltd. and Nestlé. DIREVO Industrial Biotechnology GmbH is privately owned and located in Cologne, Germany. The shareholders include Wölbern EquityPartner GmbH (Hamburg), NRW Bank (Düsseldorf), TVM Capital (Munich), Danisco A/S (Copenhagen), a private equity firm affiliated with Sparkasse KölnBonn (Cologne), SandersMorrisHarris EnzymesLLC (New York), Mulligan BioCapital (Hamburg), and several private investors.

Current Team (2)

Update

Past Team (1)

Update

Funding Rounds (3) - $33.2M

Update

Investors (7)

Update

Offices/Locations (1)

Update
  • Office

    Nattermannallee 1

    Cologne, D - 50829

    DEU

Images (1)

Update
  • 2895ee1ceedb214cff538848f01e934e